Navigation Links
Vermillion Announces Effectiveness of Reverse Stock Split
Date:3/3/2008

FREMONT, Calif., March 3 /PRNewswire-FirstCall/ -- Vermillion, Inc. (Nasdaq: VRML) (the "Company"), a high-value molecular diagnostics company, announced today that on February 29, 2008, the Company filed its Third Amended and Restated Certificate of Incorporation, which effects a 1-for-10 reverse stock split of the Company's outstanding common stock. The reverse stock split will be effective with respect to stockholders of record upon the close of business today, March 3, 2008.

The common stock will trade on the NASDAQ Capital Market under the symbol "VRMLD" for 20 trading days beginning March 4, 2008 to designate that it is trading on a post-reverse split basis, and will resume trading under the symbol "VRML" after the 20-day period has expired.

"With this reverse stock split now effective, we believe that a broader group of potential investors can purchase our shares and will recognize the value of our diagnostic programs addressing complex diseases," said Gail S. Page, President and CEO of Vermillion.

As a result of the reverse stock split, each ten shares of common stock will be combined and reclassified into one share of common stock and the total number of shares outstanding will be reduced from approximately 63.8 million shares to approximately 6.4 million shares.

The Company's transfer agent, Wells Fargo Shareowner Services, will send instructions to stockholders of record regarding the exchange of certificates for common stock.

About Vermillion

Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collab
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Vermillion and Stanford University Sign Exclusive License Agreement for Novel Biomarker Panel to Assess Peripheral Artery Disease Risk
2. Vermillion Receives NASDAQ Notice of Non-Compliance
3. Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests
4. Vermillion to Webcast Presentation at the Acumen BioFin 9th Annual Healthcare Conference, November 5-7, New York
5. Vermillion, Inc. Announces Receipt Of Notice Of Compliance From Nasdaq
6. Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
7. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
8. Rosetta Genomics Announces Allowance of Two Additional microRNA Patents
9. ROBODOC(R) Announces Patent Cross Licensing Agreement With IBM
10. MiMedx Announces Brian J. Splan as President
11. Boston Scientific Announces European Approval of New Heart Failure Lead

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...re-USNewswire/ -- The Michael J. Fox Foundation fo... million in total awards to six research teams wor...apies for Parkinson,s disease. The funding was awa... for Parkinson,s Disease program, made possible b...), a neuroscience-based biotechnology company. ,...
(Date:11/30/2009)...LOS ANGELES, Nov. 30 /PRNewswire-Asia-FirstCall/ -...n Board: CYXN; ,China Yongxin,Pharmaceuticals, or ...r and,retailer of pharmaceuticals in Northeastern ...n for distribution of medicines on the Essential D...ly formalized the nation,s Essential Drug,List whi...
(Date:11/30/2009).... 30 Exiqon A/S (NASDAQ OMX Copenh...cal School ICCB-Longwood Screening Facility (ICCB-...ter of Excellence. ICCB-L supports investigators ...s and institutions, for high-throughput screening ...NAs are a novel class of small, non-coding RNA spe...
(Date:11/28/2009)...tional Advisory Committee on Climate Change (NACCC...Project in collaboration with the Vanuatu Meteorol...d have generated preliminary climate change and se... for the country’s SNC reporting to the Unit...(UNFCCC). , Port Vila, V...
Breaking Biology Technology:The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 3Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 2Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 3Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 2Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 3Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 4
...lthcare has data from a clinical case study confi...ted tomography (CT) scanner, is capable of capturi...ts. The announcement was made at the annual meetin... ,The clinical case study data, collected by Dr. J... Radiology at Centre Cardiologique de Nord in Sain...
...ry, weve been banging the drum for business alignm... the chanting and ritual dancing in and out of con...s suggest the results are good. My favorite is the...ing measures of successful alignment is being aske... have to admit some guilty satisfaction that this ...
...ved a $500,000 start-up grant for the recently ann...on-profit group for classified, defense-related pr...echnology Council, will also initially include the...Marshfield Clinic Research Foundation, and the Mil...ll assess the capabilities of the states public an...
Other Biology Technology:GE Healthcare's CT Scanner advances coronary imaging 2Now comes the hybrid CIO 2Now comes the hybrid CIO 3Wisconsin consortium aims for defense business 2
(Date:11/25/2009)...is the linchpin of the environment, where atmosphe... many students see soil as "just dirt" a place to...tors are challenged with the task of helping stude...ce of soil in the environment. , A collaborativ...rs at University of Nebraska-Lincoln, Oregon State...
(Date:11/25/2009)...rofessors recently received funding from the Natio...beneficial to understanding the environment. The t...ood, assistant professor in the Department of Biol... separate research projects. , His first project... and Functions from the Leaf to the Landscape," wi...
(Date:11/24/2009)...escribed by traditional healers in Brazil to treat...in to fever and flu. , Now for the first time, re...o scientifically prove the pain relieving properti...an mint. , Testing this ancient South American he...cha was able to show that when prepared as a ,tea,...
Breaking Biology News(10 mins):It's not just dirt! 2Kent State University professors focus research on the environment with grants totaling $890,000 2Got a pain? -- Have a cup of Brazilian mint 2Long Term Care Financing Must Be Part of Health Care Reform 51166 1Long Term Care Financing Must Be Part of Health Care Reform 51166 2Long Term Care Financing Must Be Part of Health Care Reform 51166 3Link between migraines and reduced breast cancer risk confirmed in follow up study 51163 1Link between migraines and reduced breast cancer risk confirmed in follow up study 51163 2Duane Reade Holdings Inc Announces Cash Tender Offers for Senior Secured Floating Rate Notes and Senior Subordinated Notes and Solicitation of Conse 51161 1Duane Reade Holdings Inc Announces Cash Tender Offers for Senior Secured Floating Rate Notes and Senior Subordinated Notes and Solicitation of Conse 51161 2Duane Reade Holdings Inc Announces Cash Tender Offers for Senior Secured Floating Rate Notes and Senior Subordinated Notes and Solicitation of Conse 51161 3Duane Reade Holdings Inc Announces Cash Tender Offers for Senior Secured Floating Rate Notes and Senior Subordinated Notes and Solicitation of Conse 51161 4Duane Reade Holdings Inc Announces Cash Tender Offers for Senior Secured Floating Rate Notes and Senior Subordinated Notes and Solicitation of Conse 51161 5
...vailable in German . , Where would we be with...or, for that matter, to forget irrelevant details?...munication units, called synapses, we are good at ...pse was believed to play an active role in this re...erlie our ability to learn but also to forget. An ...
...arine animals find their way back to their birthpl...of miles of open ocean has mystified scientists fo...e University of North Carolina at Chapel Hill thin... At the beginning of their lives, salmon and sea t...rea and "imprint" on it, according to a new theory...
...cientists around the world may benefit from a powe... will help them to home in on the parts of protein...w, PhD, associate professor of pathology and of ge...ne, recently launched the novel bioinformatics too...ning the role different proteins play in a wide ar...
Other Biology News:It takes 2 to tango 2It takes 2 to tango 3No place like home: New theory for how salmon, sea turtles find their birthplace 2No place like home: New theory for how salmon, sea turtles find their birthplace 3Powerful online tool for protein analysis provided pro bono by Stanford geneticist 2Powerful online tool for protein analysis provided pro bono by Stanford geneticist 3
Bio-Plex Manager Version 3.0 to 4.0 Workstation Software Upgrade Kit from Bio-Rad
Human siTrio from B-Bridge International
...oxy Vitamin D kit is an enzymeimmunoassay intended...itamin D (25-OH D) and other hydroxylated metaboli...assay technology eliminates the inconvenience of s...ore facilitates automation on many ELISA processor...
Mouse Anti-Aggrecan xxPEN Monoclonal Antibody, Unconjugated, Clone BC-4 from Abcam
Biology Products: